The 20 Best Choledocholithiasis Doctors Near Me in Baltimore, MD

Gastroenterologist Mouen Khashab specializes in therapeutic endoscopy, and he oversees this group of practitioners across the Johns Hopkins enterprise. Nationally and internationally known in the field of interventional endoscopy, Dr. Khashab has contributed immensely to the field’s advancement as a minimally invasive means to treat gastrointestinal and pancreaticobiliary disorders. Dr. Khashab earned his medical degree from the American University of Beirut Faculty of Medicine, and subsequently completed a residency in internal medicine and a fellowship in gastroenterology at Indiana University. He then completed a two-year fellowship at The Johns Hopkins Hospital before joining the faculty in 2011. A busy researcher, Dr. Khashab has published more than 600 papers in peer-reviewed journals. In 2013, he described the procedure called gastric peroral endoscopic myotomy (known as G-POEM) and was able to disseminate and teach it all over the world. Other procedures that he expanded include peroral endoscopic myotomy (POEM), peroral endoscopic myotomy with fundoplication (POEM-F), Zenker’s peroral endoscopic myotomy (Z-POEM) and full thickness resection. In 2022, he received the Master Endoscopist Award from the American Society for Gastrointestinal Endoscopy (ASGE) for his numerous contributions to the field. His procedural expertise includes endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound (EUS), interventional EUS, submucosal endoscopy, POEM/achalasia, endoscopic mucosal resection, endoscopic submucosal dissection, luminal stenting, large polyp resection and Barrett’s therapy, among others. Dr. Khashab is involved with multiple gastrointestinal societies and has served on many committees, including the ASGE Standards of Practice Committee, which is in charge of formulating guidelines for the practice of endoscopy. He has also served as an associate editor for the journal Endoscopy, a premier journal in the field. Khashab is a highly sought-after speaker at national and international conferences, and he has participated in multiple live endoscopy conferences. Outside of academic medicine, Dr. Khashab is an entrepreneur. His major interest is in new technology and medical devices, and his goal is to disrupt the field by introducing technology that makes endoscopic procedures safer, easier, efficient and more scalable. Dr. Khashab is rated as a Distinguished provider by MediFind in the treatment of Choledocholithiasis. He is also highly rated in 53 other conditions, according to our data. His clinical expertise encompasses Achalasia, Pancreatic Pseudocyst, Bile Duct Obstruction, Endoscopy, and Gastric Bypass. Dr. Khashab is board certified in American Board Of Internal Medicine.

Dr. Akshintala received his medical degree from the Andhra Medical College in India in 2011. Following this, he completed a post-doctoral research fellowship in Gastroenterology at Johns Hopkins Hospital where he established himself as a dedicated researcher. Dr. Akshintala completed his internship and residency training in Internal Medicine at the University of Pittsburgh Medical Center in 2016. He completed his fellowship in Gastroenterology at Johns Hopkins Hospital in 2019. Dr. Akshintala then completed additional fellowships in Advanced Endoscopy and Medical Pancreatology at the Johns Hopkins Hospital in 2021. As of July 1, 2021, Dr. Akshintala is an Assistant Professor of Medicine in the Division of Gastroenterology at Johns Hopkins Hospital. Dr. Akshintala’s research is focused on the medical as well as endoscopic evaluation and treatment of inflammatory disorders of the pancreas. He is also interested in developing new devices and technologies for the care of patients with gastrointestinal disorders. Dr. Akshintala has conducted multi-national randomized-controlled trials and has won numerous awards at major national and international conferences for his research. He also has authored more than 60 original articles, editorials, book chapters and review articles. Dr. Akshintala has received grant funding from the American Society for Gastrointestinal Endoscopy (ASGE) and the Maryland State to support his research. As an innovator, Dr. Akshintala has patented new therapies for gastrointestinal bleeding and pancreas necrosis, a complication of acute pancreatitis. An internationally recognized researcher conducting multi-national clinical trials, Dr. Akshintala holds an Adjunct Assistant Professor position at the Asian Institute of Gastroenterology in India, one of the largest gastroenterology hospitals in the world. Dr. Akshintala is a Ph.D. candidate with the Dutch Pancreatitis Study Group in the Netherlands, who have been pioneered landmark clinical trials related to pancreatitis. Dr. Akshintala offers in-person clinic visits at the Baltimore location and also provides telemedicine visits for patients located in Maryland, Washington, D.C. and Virginia. Dr. Akshintala is rated as an Advanced provider by MediFind in the treatment of Choledocholithiasis. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Hereditary Pancreatitis, Acute Pancreatitis, Chronic Pancreatitis, Endoscopy, and Lithotripsy. Dr. Akshintala is board certified in American Board Of Internal Medicine.

Gastroenterologist Saowanee Ngamruengphong specializes in the endoscopic diagnosis and management of gastrointestinal malignancies, premalignant and malignant lesions in the gastrointestinal tract (e.g., early gastric cancer, Barrett's esophagus-associated neoplasia), esophageal cancer, colon polyps or early colorectal cancer, and pancreatic and biliary disease. Dr. Ngamruengphong earned a medical degree from Chulalongkorn University and completed residency training at the Texas Tech University Health Sciences Center. She undertook fellowship training in gastroenterology at the Mayo School of Graduate Medical Education and further fellowship training in therapeutic endoscopy at The Johns Hopkins Hospital. Her research interests include endoscopic resection and the management of precancerous or cancerous gastrointestinal lesions. Dr. Ngamruengphong is a member of several professional organizations, including the Thai Medical Council, the American College of Gastroenterology and the American Gastroenterological Association. Videos Endoscopic Submucosal Dissection (ESD) — Eileen’s Story Recent News Articles and Media Coverage A Rare, Stomach-Saving Endoscopic Procedure, Inside Tract (Spring 2021) Case Presentation: ESD-TAMIS, Inside Tract (Spring 2019) Innovative Approaches to Colorectal Surgery Benefit Patients, Surgery (Winter 2019) For Colorectal Polyps: Early Detection and Minimally Invasive Endoscopic Resection, Inside Tract (Winter, 2019) The Cutting Edge of Endoscopic Resection, Inside Tract (Spring, 2017) Stomach Cancer: Know Your Risks & Treatment Options, Johns Hopkins Surgery (4/26/2017). Dr. Ngamruengphong is rated as an Advanced provider by MediFind in the treatment of Choledocholithiasis. She is also highly rated in 41 other conditions, according to our data. Her clinical expertise encompasses Achalasia, Stomach Cancer, Pancreatic Pseudocyst, Endoscopy, and Gastric Bypass. Dr. Ngamruengphong is board certified in American Board Of Internal Medicine.

Dr. Duncan specializes in gastrointestinal surgical oncology, including surgery of the esophagus, stomach, intestine, colon and rectum, gallbladder and pancreas, adrenal and retroperitoneal sarcoma. He has national and international expertise in gastric cancer and hereditary gastric cancer including CDH-1. He wrote the Johns Hopkins Patient Guide for Cancer of the Stomach and Esophagus. Dr. Duncan gives lectures and presentations nationally and internationally on Gastric and GI cancer surgery and works with Johns Hopkins International on cancer programs and centers overseas. Dr. Duncan is rated as an Advanced provider by MediFind in the treatment of Choledocholithiasis. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Familial Colorectal Cancer, Gastrointestinal Stromal Tumor, Gastrectomy, and Hernia Surgery. Dr. Duncan is board certified in American Board Of Surgery.

Dr. Cunningham earned his M.D. from George Washington University and completed general surgery residency at the University of Maryland. He has completed fellowships in both oncology research and pancreatic and hepatobiliary surgery at Johns Hopkins Hospital. Throughout his career, he has been a prolific contributor and editor with over 100 contributions to a variety of medical journals, guidelines, conferences and textbooks [see Research tab]. He has also served as a Cancer Liaison Physician for the American College of Surgeons, Commission on Cancer. A member the American College of Surgeons, the Society for American Gastrointestinal & Endoscopic Surgeons, the Americas Hepato-Pancreato-Biliary Association, the International Hepato-Pancreato-Biliary Association, the Society for Surgical Oncology, the Society for Surgery of the Alimentary Tract, and the Pancreas Club, Dr. Cunningham offers world-class multidisciplinary and minimally invasive evaluation and treatment of pancreatic, biliary and liver diseases, both benign and malignant. LinkedIn https://www.linkedin.com/in/stevenccunningham. Dr. Cunningham is rated as an Advanced provider by MediFind in the treatment of Choledocholithiasis. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Biliary Dyskinesia, Gallbladder Disease, Pancreatic Cancer, Gallbladder Removal, and Pancreaticoduodenectomy. Dr. Cunningham is board certified in American Board Of Surgery.

Mariuxi Manukyan, M.D., is an assistant professor of surgery at Johns Hopkins, working primarily with the Division of Acute Care Surgery. Dr. Manukyan’s areas of clinical expertise include critical care, general surgery and trauma. Before joining Johns Hopkins, Dr. Manukyan was an acute care surgery fellow with the Department of Critical Care and Acute Care Surgery at The University of Texas Medical Center in Houston. Dr. Manukyan received her undergraduate degree from Brown University and earned her medical degree from Brown Alpert Medical School. She completed her residency at Indiana University and fellowships in acute care surgery and surgical critical care at UT Houston Medical Center. She is a member of the Association for Academic Surgery, the American College of Surgeons, the Pan American Trauma Society, the American Association for the Surgery of Trauma, and the Eastern Association for the Surgery of Trauma. Dr. Manukyan’s research interests include the field of geriatric trauma, specifically in identifying the specific risks associated within the geriatric trauma population and in finding in-hospital methods to decrease the morbidity and mortality associated with this patient population. Dr. Manukyan is rated as an Experienced provider by MediFind in the treatment of Choledocholithiasis. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Gastrointestinal Fistula, Hernia, Ogilvie Syndrome, Gastrostomy, and Hernia Surgery. Dr. Manukyan is board certified in American Board Of Surgery.

Jin He, M.D., Ph.D., is a professor of surgery at the Johns Hopkins University School of Medicine and is the Division Chief of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology. Dr. He specializes in diseases and tumors of the pancreas, liver, bile duct, and gallbladder. He performs open as well as minimally invasive (robotic and laparoscopic) surgery, including the Whipple procedure. Dr. He received his medical degree from Beijing Medical University and a Ph.D. in oncology from Fudan University Shanghai Medical College. He completed the Halsted general surgery residency training at Johns Hopkins, followed by an ACGME accredited fellowship in complex general surgical oncology at Johns Hopkins. Dr. He is the John Cameron Professor of Alimentary Tract Diseases. Dr. He’s research focuses on personalized treatment through stratifying pancreatic tumors on their genetic features. He holds several patents in anti-cancer vascular targeting agents and has published extensively in peer-reviewed journals and lectured internationally. He serves on several national committees, including the NCCN panel on neuroendocrine tumors and the Alliance for Clinical Trials in Oncology. Dr. He is rated as an Experienced provider by MediFind in the treatment of Choledocholithiasis. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Pancreaticoduodenectomy. Dr. He is board certified in American Board Of Surgery.

Dr. Benjamin Philosophe is the surgical director of the Johns Hopkins Comprehensive Transplant Center. He also serves as the lead transplant surgeon at Sibley Memorial Hospital’s Hepatology Multidisciplinary Center. Dr. Philosophe was the first physician to perform robotic total right and total left hepatic resections in the state of Maryland. He has expanded the application of minimally invasive surgical approaches to other hepatobiliary diseases and has improved outcomes and reduced effects of surgery on these patients. Dr. Philosophe practices out of The Johns Hopkins Hospital in Baltimore, Md., as well as Johns Hopkins Community Physician locations in Bethesda, Md. and Lutherville, Md. He is also affiliated with Suburban Hospital and Johns Hopkins Howard County Medical Center. Dr. Philosophe has a wide range of expertise, including cirrhosis; hepatic surgery, hepatitis, hepatobiliary conditions and surgeries; biliary tract surgery and hepatopancreatobiliary surgery; laparoscopic surgeries; vascular surgery; and robotic surgeries. He also has an expertise in various kinds of transplant surgeries, such as kidney, live donor liver, liver and pancreas, as well as various kinds of cancer, such as bile duct, gallbladder, hepatocellular, liver and pancreatic. Dr. Philosophe earned his medical degree from Boston University School of Medicine. He completed a residency in general surgery at Barnes-Jewish Hospital, followed by a liver transplantation fellowship at the University of Toronto. Dr. Philosophe also completed a transplant surgery fellowship at the University of Maryland, where he went on to work as a professor of surgery and the head of liver transplantation and hepatobiliary surgery. Dr. Philosophe is a member of the American Board of Surgery, the Clinical Robotic Surgery Association, the American Society of Transplant Surgeons, the Transplantation Society and the International Liver Transplantation Society. He has earned a Super Doctors Award in general surgery from the Washington Post Magazine, as well as a Top Doctor Award for hepatobiliary surgery and transplant specialists from Baltimore Magazine. Dr. Philosophe has also been repeatedly named one of America’s Top Doctors and one of America’s Top Doctors for Cancer by Castle Connolly. Dr. Philosophe has contributed to numerous publications and presentations. His research interests include uncovering the mechanisms that contribute to transplant rejection and determining characteristics that can be used to better predict donor organ function. He has completed pioneering work in developing a scoring system called the Maryland Aggregate Pathology Index (MAPI), which is used by transplant surgeons worldwide to assess the likelihood of a deceased donor’s kidney function after transplantation. MAPI has increased the utilization of donor kidneys and saved many lives. Dr. Philosophe is rated as an Experienced provider by MediFind in the treatment of Choledocholithiasis. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Hepatitis, End-Stage Renal Disease (ESRD), Liver Failure, Liver Transplant, and Kidney Transplant. Dr. Philosophe is board certified in American Board Of Surgery.

Alistair Kent, M.D., M.P.H., joins Johns Hopkins as assistant professor of surgery and trauma surgeon at Johns Hopkins Bayview Medical Center. Dr. Kent’s areas of clinical expertise include general surgery, trauma and acute care surgery, surgical critical care, and surgical care of medically fragile patients. Dr. Kent earned bachelor of science degrees in chemistry and mathematics from Harding University. He received his medical degree from Washington University School of Medicine and went on to earn his master of public health degree from George Washington University School of Public Health and Health Services. He completed his general surgery residency at Ohio State University, Wexner Medical Center and a trauma and acute care surgery fellowship at The Johns Hopkins Hospital. He is a member of several professional societies, including the Eastern Association for the Surgery of Trauma, the Society of Critical Care Medicine, the American College of Surgeons, the Association for Academic Surgery, Academy Health, and the American Medical Association. Dr. Kent’s research interests include studies of health care delivery systems, health care economics, geographic analysis, trauma care, and systems of care for patients with life-threatening or time sensitive illness. Selected Publications Kent A, Bahner DP, Boulger CT, Eiferman DS, Adkins EJ, Evans DC, Springer AN, Balakrishnan JM, Valiyaveedan S, Galwankar S, Njoku C, Lindsey DE, Yeager S, Roelant GJ, Stawicki SP. Sonographic evaluation of intravascular volume status in the surgical intensive care unit: a prospective comparison of subclavian vein and inferior vena cava collapsibility index. J Surg Res 2013; 184(1):561-6. PMID: 23764308 Kent A, Patil P, Davila V, Bailey JK, Jones C, Evans DC, Boulger CT, Adkins E, Balakrishnan JM, Valiyaveedan S, Galwankar SC, Bahner DP, Stawicki SP. Sonographic evaluation of intravascular volume status: Can internal jugular or femoral vein collapsibility be used in the absence of IVC visualization? Annals of Thoracic Medicine. 2015; 10(1): 44-49 PMID: PMC4286845 Genin G, Kent A, Birman V, Wopenka B, Pasteris J, Marquez P, Thomopoulos S. Functional grading of mineral and collagen in the attachment of tendon to bone. Biophysical Journal 2009; 97(4): 976-985 PMID: 19094386 Stawicki S, Kent A, Patil P, Jones C, Stoltzfus J, Vira A, Kelly N, Springer A, Vazquez D, Evans D, Papadimos T, Bahner, D. Dynamic behavior of venous collapsibility and central venous pressure during standardized crystalloid bolus: A prospective, observational pilot study. Int J Crit Illn Inj Sci. 2015; 5(2): 80-84 PMID: PMC4477400 Wopenka B, Kent A, Pasteris J, Yoon Y, Thomopoulos S. The tendon-to-bone transition of the rotator cuff: a preliminary Raman spectroscopic study documenting the gradual mineralization across the insertion in rat tissue samples. Applied Spectroscopy 2008; 62(12): 1285-1294 PMID: 19094386. Dr. Kent is rated as an Experienced provider by MediFind in the treatment of Choledocholithiasis. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Hernia, Gallbladder Disease, Gallstones, Hernia Surgery, and Gastrostomy. Dr. Kent is board certified in American Board Of Surgery.

Lilah Morris-Wiseman, M.D., F.A.C.S., is an endocrine surgeon who serves as chief of the Division of Endocrine Surgery. Dr. Morris-Wiseman came to Johns Hopkins in 2021 from the University of Arizona College of Medicine where she was an Associate Professor of Endocrine Surgery. She has a broad endocrine surgery practice using minimally invasive techniques as appropriate to facilitate excellent clinical outcomes with rapid patient recovery. Her clinical practice emphasizes patient-centered shared decision-making and excellent communication and multidisciplinary collaboration so that a patient’s surgical care occurs within an individualized context. She has been named an associate member of the American College of Surgeons' Academy of Master Surgeon Educators. Awardees are recognized for having devoted their careers to surgical education and are considered premier leaders in their respective fields. Dr. Morris-Wiseman holds committee responsibilities with multiple national organizations including the American Thyroid Association, the American Association of Endocrine Surgeons, and the Association of Program Directors in Surgery. She serves on the editorial board of Clinical Thyroidology, is a reviewer for multiple journals, and has published over 50 peer-reviewed manuscripts and book chapters. Dr. Morris-Wiseman sees patients at the Johns Hopkins Outpatient Center in Baltimore and the Johns Hopkins Health Care & Surgery Center – Green Spring Station in Lutherville. To support Dr. Morris-Wiseman's research, visit: https://secure.jhu.edu/form/morris-wiseman. Dr. Morris is rated as an Experienced provider by MediFind in the treatment of Choledocholithiasis. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Hyperparathyroidism, Familial Isolated Hyperparathyroidism, Parathyroid Hyperplasia, Thyroidectomy, and Parathyroidectomy. Dr. Morris is board certified in American Board Of Surgery.

Richard Burkhart, M.D., is an Associate Professor of Surgery at The Johns Hopkins Hospital with a focus on complex minimally-invasive surgery and research for cancers of the pancreas, liver and bile ducts. Dr. Burkhart received his medical degree from Boston University and completed his surgical residency and research fellowships at the Thomas Jefferson University Hospital in Philadelphia and the Cold Spring Harbor Laboratories. He is a member of several professional organizations, including the American Association of Cancer Research, the American College of Surgeons, the Society of Surgery for the Alimentary Tract, the Pancreas Club, and the Society of Surgical Oncology. Outside the operating room, Dr. Burkhart heads a multidisciplinary laboratory team dedicated to bringing next-generation precision medicine approaches into the routine clinical care of patients that we serve. He has a particular research interest in using personalized models of pancreas cancer, made from tumor during and immediately after surgical resection, to select the best chemotherapy for each patient to support long-term survival and improve rates of disease cure. The laboratory team, funded in part by the National Institutes of Health, the National Cancer Institute, the Lustgarten Foundation and Stand Up to Cancer, is also thankful to the many patients who have supported the work through philanthropic gift. Dr. Burkhart is rated as an Experienced provider by MediFind in the treatment of Choledocholithiasis. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Burkhart is board certified in American Board Of Surgery.

William Burns, M.D., is an assistant professor of surgery at the Johns Hopkins University School of Medicine and a surgeon within the Division of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology at The Johns Hopkins Hospital. Prior to joining the faculty at Johns Hopkins, Dr. Burns served as an assistant professor of surgery at the University of Michigan, as well as an attending physician at the University of Michigan Health Systems and the VA Ann Arbor Healthcare System. Dr. Burns received his medical degree from Yale University School of Medicine and was awarded a research training fellowship by the Howard Hughes Medical Institute. He completed an internship and residency in general surgery at The Johns Hopkins Hospital followed by clinical fellowship training in complex general surgical oncology at The University of Texas MD Anderson Cancer Center. Additionally, he completed postgraduate research fellowships in the field of cancer immunotherapy and tumor immunology at the National Cancer Institute and the MD Anderson Cancer Center. Dr. Burns specializes in treating patients with tumors of the pancreas and gastrointestinal tract, sarcoma and melanoma. He is trained in traditional and minimally invasive surgical techniques. Furthermore, he works closely with colleagues in medical and radiation oncology to provide comprehensive cancer care. His research focuses on immune cell-tumor cell interactions to improve outcomes in patients with pancreatic cancer, cancer immunotherapy for solid tumors, the role of lymph node surgery in the treatment of cancer, and human biospecimen analysis to guide therapy in patients with cancer. He is a member of several professional societies, including the American College of Surgeons, Society of Surgical Oncology, Association of Academic Surgery, and Society of Immunotherapy for Cancer. Dr. Burns is rated as an Experienced provider by MediFind in the treatment of Choledocholithiasis. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Familial Pancreatic Cancer, Familial Colorectal Cancer, Small Bowel Resection, and Pancreatectomy. Dr. Burns is board certified in American Board Of Surgery.

Dr. Stevens is an Associate Professor of Surgery at the Johns Hopkins School of Medicine and an attending surgeon at The Johns Hopkins Hospital. Dr. Stevens obtained his medical degree from the University of Arizona where he also completed his residency in general surgery. He subsequently completed a fellowship in Trauma/Surgical Critical Care at the University of Maryland, R. Adams Cowley Shock Trauma Center. During his fellowship, Dr. Stevens completed a Master of Public Health degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Stevens’ research interests center on surgical and trauma-care strengthening in resource-poor settings. Dr. Stevens is rated as an Experienced provider by MediFind in the treatment of Choledocholithiasis. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Ogilvie Syndrome, Gastrointestinal Perforation, Gastrointestinal Fistula, Hernia Surgery, and Colostomy. Dr. Stevens is board certified in American Board Of Surgery.

Peter Darwin is a Gastroenterologist practicing medicine in Baltimore, Maryland. Dr. Darwin is rated as a Distinguished provider by MediFind in the treatment of Choledocholithiasis. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Cholestasis, Bile Duct Obstruction, Bile Duct Stricture, Endoscopy, and Pancreatectomy.

Richard Betzold is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Betzold is rated as an Experienced provider by MediFind in the treatment of Choledocholithiasis. His clinical expertise encompasses Chronic Subdural Hematoma, Subdural Hematoma, Delirium, Gastrostomy, and Endoscopy.

Dr. James Facciola is a clinical instructor in the Johns Hopkins Medicine Department of Radiology and Radiological Sciences. He specializes in body magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and image-guided biopsy. Dr. Facciola graduated from the Temple University School of Medicine in 2013. He subsequently completed a preliminary surgical internship at Temple University Hospital in Philadelphia, PA followed by a diagnostic radiology residency at Temple University Hospital. Following residency, he completed a year-long fellowship in cross-sectional imaging at Johns Hopkins. Dr. Facciola’s research has included study of the anatomic changes seen in the male and female pelvis in children with bladder exstrophy. He joins the Johns Hopkins faculty in July 2019. Dr. Facciola is rated as an Experienced provider by MediFind in the treatment of Choledocholithiasis. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Pleurisy, Exstrophy of the Bladder, Pleural Effusion, and Pancreatic Cancer. Dr. Facciola is board certified in American Board Of Radiology.

Elliott Haut is a General Surgeon practicing medicine in Baltimore, Maryland. Dr. Haut is rated as an Experienced provider by MediFind in the treatment of Choledocholithiasis. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Venous Thromboembolism (VTE), Mesenteric Venous Thrombosis, Traumatic Brain Injury, Hernia Surgery, and Appendectomy. Dr. Haut is board certified in American Board Of Surgery.

Raymond Fang, M.D., joins the Johns Hopkins Department of Surgery as an Assistant Professor of Surgery and the Trauma Medical Director at Johns Hopkins Bayview Medical Center. Dr. Fang’s areas of clinical expertise include trauma surgery, surgical critical care, military medicine and patient transport/evacuation. Prior to joining Johns Hopkins, Dr. Fang served for 22 years as a wartime trauma surgeon in the United States Air Force. From 2004-2011, he proudly cared for the Nation’s Wounded Warrior as a trauma surgeon at the United States Army’s Landstuhl Regional Medical Center (LRMC), Germany, the receiving hospital for all casualties evacuated from Iraq, Afghanistan and Africa. His efforts were essential in LRMC’s verification as the first American College of Surgeons (ACS) Level II trauma center outside of the United States in 2007. He was appointed Chief, LRMC Trauma Program in 2009 and led its ACS Level II re-verification in 2010, and its elevation to ACS Level I status in 2011. In 2011, Dr. Fang became the Director, United States Air Force Center for the Sustainment of Trauma and Readiness Skills embedded within the University of Maryland’s R Adams Cowley Shock Trauma Center, Baltimore, Maryland. In this role, he prepared Air Force Medical Service personnel to deploy in support of operations worldwide by immersing them in trauma care while personally providing trauma and emergency care to the citizens of Maryland. He held a faculty appointment as a Clinical Associate Professor of Surgery with the University of Maryland School of Medicine. Dr. Fang received his undergraduate degrees in Biochemistry and Economics from the University of California, Berkeley, and earned his medical degree (cum laude) from the Saint Louis University School of Medicine. He completed his general surgery training at the combined United States Air Force/University of Texas Health Sciences Center at San Antonio training program. He performed a Critical Care fellowship at San Antonio Uniformed Services Health Education Consortium. Dr. Fang is a member and holds leadership and committee positions with various organizations, including the American College of Surgeons, the Society of Critical Care Medicine, and the Eastern Association for the Surgery of Trauma. He is also a lifetime member of the Association of Military Surgeons of the United States. Dr. Fang’s research interests include the initial resuscitation of injured patients, the diagnosis and management of traumatic brain injuries, trauma program and trauma system development, medical simulation training, and trauma performance improvement and patient safety. As an academic surgeon-researcher, Col Fang is an author of 47 published, peer-reviewed medical articles and 9 book chapters. He has presented nearly 200 papers and invited lectures at regional, national and international meetings. Dr. Fang is rated as an Experienced provider by MediFind in the treatment of Choledocholithiasis. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Ear Barotrauma, Subdural Hematoma, Chronic Subdural Hematoma, Gastrostomy, and Hernia Surgery. Dr. Fang is board certified in American Board Of Surgery.

John Affronti is a Gastroenterologist practicing medicine in Baltimore, Maryland. Dr. Affronti is rated as an Experienced provider by MediFind in the treatment of Choledocholithiasis. His clinical expertise encompasses Childhood Volvulus, Portal Hypertension, Indigestion, Endoscopy, and Gastrectomy. Dr. Affronti is board certified in American Board Of Internal Medicine.

Dr. Magnuson specializes in gastrointestinal surgery, including surgeries of the stomach, gallbladder, pancreas and bowel. He has a special interest in bariatric surgery and established the Johns Hopkins Center for Bariatric Surgery in 1997. In 2006, the program was recognized as a Center of Excellence by the American Society for Bariatric Surgery. Dr. Magnuson completed his specialty training in gastrointestinal surgery at The Johns Hopkins Hospital, where he also completed a fellowship investigating issues related to gallstone pathogenesis and biliary tract disease. He is also a member of the Johns Hopkins Comprehensive Hernia Center. He is currently Chair of the Department of Surgery and Chief of General Surgery at Johns Hopkins Bayview Medical Center, and Vice Chair of Surgery at Johns Hopkins. Dr. Magnuson is rated as an Experienced provider by MediFind in the treatment of Choledocholithiasis. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Hernia, Obesity, Gallstones, Gastric Bypass, and Gastrectomy. Dr. Magnuson is board certified in American Board Of Surgery.